Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk
James A. de Lemos, MD* ,
Charles H. Hennekens, MD|| and
Paul M. Ridker, MD, FACC* ||
* Center for Cardiovascular Disease Prevention, Brigham and Womens Hospital, Boston, Massachusetts, USA
the Leducq Center for Molecular and Genetic Epidemology of Cardiovascular Disease; Division of Cardiovascular Medicine, Brigham and Womens Hospital, Boston, Massachusetts, USA
Division of Preventive Medicine, Brigham and Womens Hospital, Boston, Massachusetts, USA
|| Department of Medicine, University of Miami School of Medicine, Miami, Florida, USA

View larger version (11K):
[in a new window]
|
Figure 1 Relative risk (95% confidence interval) for first MI associated with a baseline sVCAM-1 concentration the 75th percentile, according to year of follow-up.
|
|
|